Summary | Pfizer Inc said Tuesday it will invest $350 million
in Hangzhou, eastern China on a plant for biotechnology drugs,
bolstering its presence in the world's second biggest
pharmaceutical market despite slowing economic growth in the
country and rising pressure on prices for medicines.
chinadaily.com.cn | 09 October 2017